Cybersecurity Challenges and Data Protection Strategies for Life Sciences and Other Tech Companies “Data is the new oil,” a phrase
Is artificial intelligence a boon or a bane—or perhaps a bit of both? Just a few years ago, discussions about
Avoid These 5 Common Startup Equity Mistakes Keeping to the fundamentals can be tough. As a busy startup founder, it’s
How AI Is Shaping Life Sciences: Challenges, Risks and Future Prospects Artificial intelligence (“AI”) has become a buzzword—almost every article,
We recently attended an insightful seminar on biotech manufacturing that we’d like to share with you. On September 13, 2024,
Artificial intelligence has become a buzzword—every article, news bulletin, podcast, and other digital media seems to mention it. Looking back
The expedited drug approval process by the U.S. Food and Drug Administration (FDA) is a double-edged sword. Designed to bring
The National Venture Capital Association (“NVCA”) has innovated again in venture capital. They’ve updated their standard template legal documents, a
Great news for prevention of respiratory syncytial virus (“RSV”) infections! Here’s a quick summary of the article: RSV is a common
Have you ever heard of a tar baby? In the 1946 Disney animated film “Song of the South” (now banned
Big news on the legal front! The U.S. District Court for Northern Alabama has just ruled that the Federal Corporate Transparency Act
We are delighted to report a new recognition for Nariman Farvardin, President of Stevens Institute of Technology. He is to
Artificial intelligence systems will be the savior of mankind! Artificial intelligence systems will doom mankind! Which statement is true?? Who knows
The BioNJ 31st Annual Dinner Meeting and Innovation Celebration, held on February 8, 2024, was a significant event that showcased
Sometimes a technical innovation fails to deliver improved patient outcomes. An example may be robotic-assisted knee replacements. Robotic-assisted knee replacements,
Did you know that the Federal government could be your “partner” in ownership of your patent rights? That could happen
Stage2Startups has a wonderful focus. It seeks to help “mature” entrepreneurs who have had a lot of “life experience” start new
I’m happy to send congratulations to my friend and colleague, Lisa Policare, CEO of Penn Wealth Planning on being recognized
Small privately-held companies will have new compliance burdens starting in the new year. The Federal Corporate Transparency Act (“CTA”) will
Bio NJ has some tremendous opportunities for C-suite executives at life sciences companies. Bio NJ has established a networking and
Here’s a great opportunity for those interested in biomedical research and entrepreneurship. The Biomedical Engineering Department at Stevens Institute of Technology
Orphan drug development is a crucial and complex area of pharmaceutical research. It’s dedicated to creating treatments for rare diseases.
Losing one’s sight is one of the cruelest types of disabilities. We depend on that sense for so much of
A significant new reporting requirement started on January 1, 2024. The Federal Corporate Transparency Act requires that most small limited
I’m sending congratulations to my friends and fellow lawyers, Ralph Selitto and John Kim. Both are experienced intellectual property lawyers
Crowley Law LLC is proud to support Hope Through Education and their mission is to help thousands of underprivileged students reach their full potential through the gift of a great education. Learn more about this organization.
